Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children — Indianapolis, Indiana

Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children has participated in 1 clinical trials.

Therapeutic areas: Sickle Cell Disease, Iron Overload, Hemolytic Anemia.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children?

Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children conducted?

Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children has 1 clinical trials on record. Their work covers Sickle Cell Disease, Iron Overload, Hemolytic Anemia.

Is Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children accredited by Crixeo Clinical Trials?

Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pediatric Sickle Cell Program/James Whitcomb Riley Hospital for Children?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.